Current Status and Future Perspectives of Checkpoint Inhibitor Immunotherapy for Prostate Cancer: A Comprehensive Review

The clinical spectrum of prostate cancer (PCa) varies from castration-naive to metastatic castration-resistant disease. Despite the administration of androgen synthesis inhibitors and chemotherapy regimens for castration-resistant prostate cancer, the treatment options for this entity are limited. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Tae Jin, Koo, Kyo Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432105/
https://www.ncbi.nlm.nih.gov/pubmed/32751945
http://dx.doi.org/10.3390/ijms21155484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432105/
https://www.ncbi.nlm.nih.gov/pubmed/32751945
http://dx.doi.org/10.3390/ijms21155484

Ejemplares similares